Trial document
This trial has been registered retrospectively.
DRKS00014760
Trial Description
Title
Analysis of glioblastoma-metabolism by MRI-Spectroscopy
Trial Acronym
[---]*
URL of the Trial
[---]*
Brief Summary in Lay Language
In a joint research project of the clinic of neurosurgery and the clinic of neuroradiology Kiel we aim to examine the metabolism of intracerebral Tumors with MR-spectroscopy. This research focused on getting further information about the so called Warburg-effect. This effect describes the suspicion that tumor cells gain energy through an oxygen-independent metabolism despite the availability of oxygen. This mechanism could enable the tumor cells to cover the demand of the high energy requirement caused by fast tumor growth.
By a special MR-examination, the MR-spectroscopy, it is possible to measure the morphological distribution of metabolites and quantify them. We are especially interested in the distribution of lactate, which is one if the produced metabolites concerning the Warburg-effect.
Brief Summary in Scientific Language
The Glioblastoma multiforme is the most common and most malign primary brain tumor. Currently there are still no curative therapy-regimes available. Responsible for this poor prognosis are b.o. the fast growth of the tumor although there are no energy substrates available and the early migration of the tumor cells. To enable this aggressive attributes the tumor cells are able to undergo molecular changes, which f.e. lead to a change of the metabolism.
Already in the 20th century a German scientist and later Nobelist Otto Warburg hypothesized that the raised lactate-levels of Tumor cells are caused by an oxygen independent glycolysis of the cells. This process, since then named Warburg effect and hallmark of severe tumorentities, seems to be an adjustment mechanism enabling the tumor cells to cover the high energy demand caused by fast tumor growth.
Meanwhile a diagnostic procedure found its way into daily work which can provide important information about the metabolism of intracranial Tumors without being invasive or using ionizing radiation. The hereby described MR-sprectroscopy just takes a few minutes and is already used to further distinguish between primary brain tumors and metastasis. Lactate is one of the hereby measured metabolites. Molecular-biological examinations let us suggest that lactate is mostly exported in the hypoxic center of the Glioblastoma and gets again absorbed in the vesiculated tumor parts for producing energy. In this field further detailed studies using MR-spectroscopy are currently not available.
In this setting we plan to exploit preoperative MR-spectroscopies of brain tumors.
Do you plan to share individual participant data with other researchers?
No
Description IPD sharing plan:
[---]*
Organizational Data
- DRKS00014760
- 2019/03/05
- [---]*
- yes
- Approved
- D 444/18, Ethikkommission der Christian-Albrechts-Universität zu Kiel
Secondary IDs
- [---]*
Health Condition or Problem studied
- C71.9 - Malignant neoplasm: Brain, unspecified
Interventions/Observational Groups
- In the study, an MRI spectroscopy (a measurement lasting only a few minutes) is carried out in order to be able to detect any differences in tumor metabolism in the tumor center and peripheral area. All patients are examined who are suspected of having a brain-specific tumor and who have given their consent after detailed information. A total of at least 10 patients should be examined.
Characteristics
- Non-interventional
- Other
- Single arm study
- Open (masking not used)
- [---]*
- Uncontrolled/Single arm
- Basic research/physiological study
- Single (group)
- N/A
- N/A
Primary Outcome
Minimum 10 patients should be examinated with MRS (magnetic resonance spectroscopy). The results of edge and central regions of the tumor will be compared.
Secondary Outcome
The data-research is to be continued for about three years.
Countries of Recruitment
- Germany
Locations of Recruitment
- University Medical Center
Recruitment
- Actual
- 2018/05/14
- 20
- Monocenter trial
- National
Inclusion Criteria
- Both, male and female
- 18 Years
- no maximum age
Additional Inclusion Criteria
Intracranial tumors
Exclusion Criteria
in need of protection (children)
Addresses
-
start of 1:1-Block address primary-sponsor
- Abt. Neurochirurgie UKSH Kiel
- Mr. Prof. Michael Synowitz
- Arnold-Heller-Str. 3
- 24105 Kiel
- Germany
end of 1:1-Block address primary-sponsorstart of 1:1-Block address contact primary-sponsor- 043169027033
- [---]*
- michael.synowitz at uksh.de
- [---]*
end of 1:1-Block address contact primary-sponsor -
start of 1:1-Block address scientific-contact
- Klinik für Neurochirurgie am UKSH, Campus Kiel
- Ms. Dr. med. Carolin Kubelt
- Arnold-Heller-Straße 3
- 24105 Kiel
- Germany
end of 1:1-Block address scientific-contactstart of 1:1-Block address contact scientific-contact- 0431-500-69614
- [---]*
- Carolin.Kubelt at uksh.de
- http://neurochirurgie-kiel.uk-sh.de
end of 1:1-Block address contact scientific-contact -
start of 1:1-Block address public-contact
- Klinik für Neurochirurgie am UKSH, Campus Kiel
- Ms. Dr. med. Carolin Kubelt
- Arnold-Heller-Straße 3
- 24105 Kiel
- Germany
end of 1:1-Block address public-contactstart of 1:1-Block address contact public-contact- 0431-500-69614
- [---]*
- Carolin.Kubelt at uksh.de
- http://neurochirurgie-kiel.uk-sh.de
end of 1:1-Block address contact public-contact
Sources of Monetary or Material Support
-
start of 1:1-Block address materialSupport
- Klinik für Neurochirurgie am UKSH, Campus Kiel
- Mr. Prof. Michael Synowitz
- Arnold-Heller-Straße 3
- 24105 Kiel
- Germany
end of 1:1-Block address materialSupportstart of 1:1-Block address contact materialSupport- 0431-500-23601
- [---]*
- michael.synowitz at uksh.de
- http://neurochirurgie-kiel.uk-sh.de
end of 1:1-Block address contact materialSupport
Status
- Recruiting complete, follow-up complete
- 2020/04/15
Trial Publications, Results and other Documents
- [---]*